featured
Topical Submicron Particle Paclitaxel for Cutaneous Metastases of Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Breast Cancer Research and Treatment
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase 1/2 study of topical submicron particle paclitaxel for cutaneous metastases of breast cancer
Breast Cancer Res Treat 2022 Apr 26;[EPub Ahead of Print], ME Lacouture, SB Goldfarb, A Markova, SP Chawla, K Dewnani, M Iacobucci, JE LangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.